NCT07147621View on ClinicalTrials.gov

Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies

Not yet recruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2027

Conditions
Acute Myeloid LeukemiaHodgkin's LymphomaNon-Hodgkin's Lymphoma
Trial Locations (1)

49933

University Hospital of Angers, Angers

All Listed Sponsors
lead

University Hospital, Angers

OTHER_GOV

NCT07147621 - Evaluation of Chemotherapy-induced Cognitive Disorders During the Treatment of Hematological Malignancies | Biotech Hunter | Biotech Hunter